$IONS 3 SEC Filings

Filed On	Filing
08 Jun 2026	Form 3: Reikes Peter N, Director No securities owned
08 Jun 2026	Form 3: Hantson Ludwig, Director No securities owned
06 Jan 2026	Form 3: Kordasiewicz Holly B., EVP, Chief Development Officer Holds 7,740 shares of Common Stock
01 Oct 2024	Form 3: Devers Shannon L., EVP, Chief Human Resourses Ofc Holds 7,909 shares of Common Stock
13 Mar 2024	Form 3: Jenne Kyle, EVP, Chf GL Pdt Str Ofcr Holds 1,989 shares of Common Stock
18 Dec 2023	Form 3: Yang Michael J., Director No securities owned
24 Mar 2023	Form 3: Birchler Brian, EVP, Corp and Development Ops Holds 35,325 shares of Common Stock
02 Feb 2022	Form 3: Baroldi Joseph, Chief Business Officer Holds 3,613 shares of Common Stock
09 Jun 2021	Form 3: Diaz Allene M., Director No securities owned
06 Jan 2021	Form 3: Schneider Eugene, EVP, Chf Clinical Develop Offc Holds 2,118 shares of Common Stock
13 Jan 2020	Form 3: Cadoret-Manier Onaiza, Chief Corp Dev and Cml Officer Holds 0 shares of No Securities Owned
03 Jan 2020	Form 3: Swayze Eric, SVP, Research Holds 768 shares of Common Stock
12 Jun 2019	Form 3: Herman Joan E, Director Holds 0 shares of No Securities Owned
25 Sep 2018	Form 3: Hayden Michael R, Director Holds 0 shares of Common Stock
24 Sep 2018	Form 3: Reikes Peter N, Director Holds 0 shares of No Securities Owned
18 Jun 2018	Form 3: McDevitt Damien, Chief Business Officer Holds 0 shares of No Securities Owned
13 Jul 2017	Form 3: Ionis Pharmaceuticals Inc, 10% owner · AKCEA THERAPEUTICS, INC.
05 Jan 2015	Form 3: Boyce Sarah, Chief Business Officer Holds 0 shares of No Securities Owned
05 Feb 2014	Form 3: Loscalzo Joseph, Director Holds 0 shares of No Securities Owned
26 Jun 2013	Form 3: Castleman Breaux, Director Holds 0 shares of No securities owned

Comments